James C. Czirr, Director, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), sold 10,000 shares at $2.16 ($22K) on 2021-04-01, disclosed to the SEC on 2021-04-05.
Scheduled sale ($22k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |